DNA Methylation Clock Drift at Glial Promoters

Target: DNA Methylation Clock Composite Score: 0.480 Price: $0.48 Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

⚠ Thin Description⚠ Low Validation Senate Quality Gates →

Quality Report Card click to collapse

Composite: 0.480

Top 78% of 1374 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

C+ Mech. Plausibility 15% 0.55 Top 67%

C+ Evidence Strength 15% 0.55 Top 55%

C+ Novelty 12% 0.50 Top 91%

C+ Feasibility 12% 0.55 Top 53%

C+ Impact 12% 0.55 Top 73%

C+ Druggability 10% 0.55 Top 54%

D Safety Profile 8% 0.35 Top 88%

C Competition 6% 0.40 Top 93%

C+ Data Availability 5% 0.50 Top 68%

C Reproducibility 5% 0.40 Top 85%

Evidence

5 supporting | 0 opposing

Citation quality: 0%

Debates

1 session A+

Avg quality: 1.00

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

Investigate shared DNA methylation age acceleration and histone modification patterns (H3K27me3, H3K4me3, H3K9me3, acetylation) across Alzheimer disease, Parkinson disease, and ALS. Identify common epigenetic signatures that distinguish these neurodegenerative diseases from normal aging.

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Senescence-Associated Epigenetic Phenotype (SEP)

Score: 0.620 | Target: Senescence-Associated Epigenetic Phenotype

REST Complex Dysregulation as Master Epigenetic Switch

Score: 0.570 | Target: REST

H3K9me3 Heterochromatin Loss at Pericentromeric Repeats

Score: 0.565 | Target: H3K9me3 Heterochromatin

Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes

Score: 0.530 | Target: Polycomb-to-Trithorax Switch at

Bivalent Domain Resolution Failure at Neurodevelopment Genes

Score: 0.410 | Target: Bivalent Domain Resolution

Mitochondrial-to-Nuclear Epigenetic Communication via N-formylmethionine

Score: 0.295 | Target: Mitochondrial-to-Nuclear Epigenetic Communication

→ View full analysis & all 7 hypotheses

Description

DNA Methylation Clock Drift at Glial Promoters

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 5 with PMID 5 medium Validation: 0% 5 supporting / 0 opposing

✓ For (5)

No opposing evidence

(0) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 4CLIN 0GENE 1EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
DNA structure and function.	Supporting	MECH	FEBS J	MEDIUM	2015	-	PMID:25903461	-
PARP1-DNA co-condensation drives DNA repair site a…	Supporting	GENE	Cell	MEDIUM	2024	-	PMID:38320550	-
Homologous recombination and the repair of DNA dou…	Supporting	MECH	J Biol Chem	MEDIUM	2018	-	PMID:29599286	-
DNA-Origami-Armored DNA Condensates.	Supporting	MECH	Chembiochem	MEDIUM	2024	-	PMID:39075031	-
Regulation of Human DNA Primase-Polymerase PrimPol…	Supporting	MECH	Biochemistry (M…	MEDIUM	2023	-	PMID:37758313	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 5

DNA structure and function. MEDIUM

FEBS J · 2015 · PMID:25903461

PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends. MEDIUM

Cell · 2024 · PMID:38320550

Homologous recombination and the repair of DNA double-strand breaks. MEDIUM

J Biol Chem · 2018 · PMID:29599286

DNA-Origami-Armored DNA Condensates. MEDIUM

Chembiochem · 2024 · PMID:39075031

Regulation of Human DNA Primase-Polymerase PrimPol. MEDIUM

Biochemistry (Mosc) · 2023 · PMID:37758313

✗ Opposing Evidence 0

No evidence recorded

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-20 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Novel Therapeutic Hypotheses: Epigenetic Signatures in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation as a Master Epigenetic Switch Across AD, PD, and ALS

Description: The RE1-Silencing Transcription factor (REST) normally protects neurons by repressing pro-apoptotic and oxidative stress genes through recruitment of CoREST complexes containing HDAC1/2 and G9a. In neurodegenerative diseases, REST is paradoxically sequestered in the cytoplasm (in AD) or downregulated (in ALS), leading to derepression of target genes and histone hyperacetylation at neuronal promoters

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Critical Evaluation of Epigenetic Hypotheses in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation

Specific Weaknesses

Mechanistic conflation across diseases: The hypothesis treats three distinct molecular phenomena—REST cytoplasmic sequestration (AD), REST downregulation (ALS), and "transcriptional repression alterations" (PD)—as amenable to a single therapeutic intervention. This ignores fundamental mechanistic differences in how REST function is compromised.

Evidence quality disparity: The AD-REST evidence (Lu et al.) derives from postmortem tissue corre

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Drug Development Feasibility Assessment: Epigenetic Hypotheses in Neurodegeneration

Executive Summary

After critical evaluation, the seven hypotheses range from moderately actionable (H6: Senolytic-epigenetic combination) to essentially undruggable (H7: N-formylmethionine pathway). The primary bottleneck across most targets is not identifying compounds, but achieving cell-type-specific CNS delivery and demonstrating target engagement in relevant tissues. Below I provide detailed drug development realities for each hypothesis.

Hypothesis 1: REST Complex Dysregu

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

No price history recorded yet

7d Trend

↔

Stable

7d Momentum

▲ 0.0%

Volatility

Low

0.0000

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

Paper:25903461

No extracted figures yet

Paper:29599286

No extracted figures yet

Paper:37758313

No extracted figures yet

Paper:38320550

No extracted figures yet

Paper:39075031

No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (1)

📓 Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS — Analysis Notebook

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

KG Entities (6)

DNA Methylation Clock H3K9me3 Heterochromatin Polycomb-to-Trithorax Switch at REST Senescence-Associated Epigenetic Phenoty neurodegeneration

Related Hypotheses

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

Score: 0.990 | neurodegeneration

TREM2-Dependent Microglial Senescence Transition

Score: 0.950 | neurodegeneration

PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction

Score: 0.941 | neurodegeneration

Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Prediction

Score: 0.933 | neurodegeneration

CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal

Score: 0.921 | neurodegeneration

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (5 edges)

implicates in (5)

Senescence-Associated Epigenetic Phenotype→neurodegenerationREST→neurodegenerationH3K9me3 Heterochromatin→neurodegenerationPolycomb-to-Trithorax Switch at→neurodegenerationDNA Methylation Clock→neurodegeneration

Mechanism Pathway for DNA Methylation Clock

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    Senescence_Associated_Epi["Senescence-Associated Epigenetic Phenotype"] -->|implicates in| neurodegeneration["neurodegeneration"]
    REST["REST"] -->|implicates in| neurodegeneration_1["neurodegeneration"]
    H3K9me3_Heterochromatin["H3K9me3 Heterochromatin"] -->|implicates in| neurodegeneration_2["neurodegeneration"]
    Polycomb_to_Trithorax_Swi["Polycomb-to-Trithorax Switch at"] -->|implicates in| neurodegeneration_3["neurodegeneration"]
    DNA_Methylation_Clock["DNA Methylation Clock"] -->|implicates in| neurodegeneration_4["neurodegeneration"]
    style Senescence_Associated_Epi fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style REST fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_1 fill:#ef5350,stroke:#333,color:#000
    style H3K9me3_Heterochromatin fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_2 fill:#ef5350,stroke:#333,color:#000
    style Polycomb_to_Trithorax_Swi fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_3 fill:#ef5350,stroke:#333,color:#000
    style DNA_Methylation_Clock fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_4 fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 DNA — Search for structure Click to search RCSB PDB

🔍 Searching RCSB PDB for DNA structures...

Querying Protein Data Bank API

Source Analysis

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

neurodegeneration | 2026-04-18 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

DNA Methylation Clock Drift at Glial Promoters

Hypotheses from Same Analysis (6)

Description

Dimension Scores

✓ Supporting Evidence 5

✗ Opposing Evidence 0

Novel Therapeutic Hypotheses: Epigenetic Signatures in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation as a Master Epigenetic Switch Across AD, PD, and ALS

Critical Evaluation of Epigenetic Hypotheses in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation

Specific Weaknesses

Drug Development Feasibility Assessment: Epigenetic Hypotheses in Neurodegeneration

Executive Summary

Hypothesis 1: REST Complex Dysregu

Price History

Clinical Trials (0)

📚 Cited Papers (5)

📙 Related Wiki Pages (0)

📓 Linked Notebooks (1)

⚔ Arena Performance

🔄 Related Hypotheses

Hypotheses from Same Analysis (6)

🧬 Same Target Gene / Disease (30)

KG Entities (6)

Related Hypotheses

Estimated Development

🧪 Falsifiable Predictions

Knowledge Subgraph (5 edges)

implicates in (5)

Mechanism Pathway for DNA Methylation Clock

3D Protein Structure

Source Analysis

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

Community Feedback